Research
Macro partitioning
Preservation of lean mass during GLP-1/GIP-induced weight loss requires high-quality protein distribution (1.2–1.5 g/kg/day) and resistance exercise to mitigate sarcopenia and maintain oncologic treatment tolerance.
To prevent muscle loss while on GLP-1/GIP drugs, eat 1.2–1.5 grams of protein per kilogram of body weight daily, spread across meals, and engage in regular resistance exercise.
GoodSupportsHIGH confidence
Rapid pharmacologically assisted reductions in body weight can improve the metabolic milieu yet jeopardize lean mass without targeted support. Practical levers include distributing high-quality protein across meals (often in the ~1.2–1.5 g/kg/day range in at-risk adults...), pairing therapy with progressive resistance exercise...
Why this rating
Strong mechanistic rationale and clinical guidelines support, though direct RCT evidence in GLP-1 oncology populations is sparse.
Source
GLP-1/GIP agonists and cancer: mechanisms, evidence, and nutrition implications
Sedat Arslan et al. · Academia oncology. · 2026
DOI 10.20935/acadonco8234
narrative_review
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Macro partitioning
- Total daily protein intake of 1.6 g/kg/day is sufficient for maximizing resistance training-induced muscle gains, with an upper confidence interval of 2.2 g/kg/day.Strong
- Resistance exercise training combined with sufficient dietary protein intake acts synergistically to maximize skeletal muscle hypertrophy, with protein intake saturating around 1.6 g/kg/day for general populations and potentially requiring 2.0-2.2 g/kg/day for resistance-trained individuals.Strong
- Trans fats should be completely eliminated from the diet, as they increase LDL cholesterol, decrease HDL cholesterol, and are directly associated with increased coronary risk.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →